# Encompass Health Corporation (EHC) Stock Analysis: Evaluating a 23.68% Upside Potential

- Link: https://www.directorstalkinterviews.com/encompass-health-corporation-ehc-stock-analysis-evaluating-a-23-68-upside-potential/4121265394
- Published: 2026-10-05T10:20:46+01:00
- Author: Madison Wilson

Encompass Health Corporation (NYSE: EHC) stands as a robust player in the healthcare
sector, specifically within the medical care facilities industry. With a market 
capitalization of $11.82 billion, this Birmingham, Alabama-based company specializes
in operating inpatient rehabilitation hospitals across the United States and Puerto
Rico. Encompass Health offers a comprehensive suite of services, including specialized
rehabilitative treatment for patients recovering from major injuries or illnesses,
with a focus on regaining functional ability and independence.

As of the latest price data, EHC is trading at $119.8, reflecting a slight price
change of 0.74 (0.01%). The stock’s 52-week range of $93.83 to $127.18 indicates
a notable recovery trajectory, suggesting a resilient performance amid market fluctuations.

From a valuation perspective, Encompass Health’s forward P/E ratio is 17.94. While
other valuation metrics such as the PEG ratio, Price/Book, and Price/Sales are not
available, the forward P/E offers a glimpse into the company’s earnings expectations.
The healthcare provider has demonstrated commendable revenue growth of 9.60%, reinforcing
its capacity to expand despite market challenges. However, specifics on net income
remain undisclosed, leaving analysts to focus on the company’s earnings per share(
EPS) of $5.98 and a robust return on equity (ROE) of 24.97% as indicators of profitability.

Encompass Health’s ability to generate free cash flow, reported at approximately
$229.92 million, underpins its financial stability and capacity to reinvest in growth
opportunities or return value to shareholders through dividends. Currently, the 
company offers a dividend yield of 0.70% with a conservative payout ratio of 12.71%,
striking a balance between rewarding shareholders and retaining capital for future
expansion.

Investor confidence is further bolstered by unanimous analyst ratings, comprising
13 buy recommendations and no hold or sell ratings. This optimistic outlook is reflected
in the target price range of $140.00 to $155.00, with an average target price of
$148.17, indicating a potential upside of 23.68%. Such a promising prospect underscores
the stock’s appeal for investors seeking growth opportunities within the healthcare
sector.

Technical indicators provide additional insights, with the 50-day moving average
standing at $120.41, slightly above the current trading price, and the 200-day moving
average at $108.18, showcasing an upward trend. The Relative Strength Index (RSI)
at 59.83 suggests that the stock is approaching overbought territory, while the 
MACD of 0.28 compared to the signal line of 0.78 indicates a potential bullish trend.

Encompass Health’s strategic focus on delivering rehabilitative care through its
extensive network of facilities and services positions it favorably within the healthcare
market. The company’s evolution from HealthSouth Corporation, its former identity
until January 2018, to its current standing, reflects its adaptive strategies in
addressing complex medical needs, including stroke, neurological disorders, and 
orthopedic conditions.

For individual investors, Encompass Health Corporation presents a compelling investment
case. The combination of a solid growth trajectory, favorable analyst ratings, and
potential for significant upside makes EHC a noteworthy consideration for portfolios
focused on healthcare innovation and resilience.

Share on: